Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dermapharm Holding SEDMPHF 53 Market Cap is $2,281 Mil as of Aug. 14, 2026. GuruFocus rates DMPHF with a GF Score™ of 53/100. The stock has 5 warning signs investors should review. Among 1,022 Drug Manufacturers companies, Dermapharm Holding SE ranks better than 85.71% on this metric.
Dermapharm Holding SE's quarterly market cap
stayed the same
from Sep. 2025 ($2,130 Mil) to Dec. 2025 ($2,130 Mil) but then
declined
from Dec. 2025 ($2,130 Mil) to Mar. 2026 ($1,960 Mil).
Dermapharm Holding SE's annual market cap
stayed the same
from Dec. 2023 ($2,298 Mil) to Dec. 2024 ($2,298 Mil) but then
declined
from Dec. 2024 ($2,298 Mil) to Dec. 2025 ($2,130 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dermapharm Holding SE's Enterprise Value for Today is $3,255 Mil.
Dermapharm Holding SE (OTCPK:DMPHF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermapharm Holding SE Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Market Cap distribution charts can be found below:
* The bar in red indicates where Dermapharm Holding SE's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Dermapharm Holding SE's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermapharm Holding SE (DMPHF) has a Market Cap of $2,281 Mil as of Aug. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dermapharm Holding SE and its competitors. According to the industry distribution chart, Dermapharm Holding SE ranks #146 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 14.3%.
Is Dermapharm Holding SE's Market Cap too high?
Dermapharm Holding SE's current Market Cap is $2,281 Mil. The Drug Manufacturers industry median Market Cap is 224.79. Dermapharm Holding SE's value of $2,281 Mil is 914.7% above this industry median. Based on the distribution chart, Dermapharm Holding SE ranks #146 out of 1022 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dermapharm Holding SE has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dermapharm Holding SE ranks #146 out of 1022 companies for Market Cap. This places Dermapharm Holding SE in the top 14% of its industry — outperforming the majority of peers. The industry median Market Cap is 224.79. Dermapharm Holding SE's value of $2,281 Mil is 914.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 224.79, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dermapharm Holding SE's current Market Cap of $2,281 Mil is 914.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dermapharm Holding SE and its competitors. For the Drug Manufacturers industry, the median Market Cap is 224.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dermapharm Holding SE's current Market Cap is $2,281 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Dermapharm Holding SE (DMPHF) has a current Market Cap of $2,281 Mil. The current Market Cap is $2,281 Mil and 914.7% above the Drug Manufacturers industry median of 224.79. Dermapharm Holding SE's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Dermapharm Holding SE (DMPHF), the current Market Cap is $2,281 Mil as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
53GF Score
Get the complete analysis for DMPHF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMPHF has been successfully added to your 
